2m 2m 2m 2m 2m 2m 2m
Vanda Pharma (VNDA)
NASDAQ
$5.32+$0.04 (+0.76%)
Price as of Aug 21, 2026 7:36 PM EDT- $319.2MMarket Cap
- 11.16%1-Year Change
- BiotechnologyIndustry
Vanda Pharma (VNDA)
$5.32+$0.04 (+0.76%)
VNDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.28 | ||
Change | -$0.10 (-1.86%) | ||
Open | $5.42 | ||
High | $5.42 | ||
Low | $5.26 | ||
Previous Close | $5.38 | ||
Volume | 656,793 | ||
30-Day Average Volume | 1,006,554 | ||
1-Week Change | 1.15% | ||
1-Month Change | -3.65% | ||
1-Year Change | 11.16% | ||
3-Year Change | -11.11% | ||
5-Year Change | -66.60% | ||
Fundamentals | |||
Shares Outstanding | 60.5M | ||
Total Assets | $412.5M | ||
Market Cap | $319.2M | ||
Enterprise Value | $263.4M | ||
Period: QTR TTM FY | |||
Revenue | $50.5M | ||
Net Income | -$62.5M | ||
Free Cash Flow | -$31.3M | ||
EBIT | -$62.4M | ||
EBITDA | -$60.4M | ||
Net Working Capital | $100.5M | ||
EPS | -$1.04 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 5 | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue